Documento de consenso de la Sociedad Española de Neurología sobre el tratamiento de la esclerosis múltiple y manejo holístico del paciente 2023

Autor: Meca-Lallana, J.E., Martínez Yélamos, S., Eichau, S., Llaneza, M.A., Martín Martínez, J., Peña Martínez, J., Meca Lallana, V., Alonso Torres, A.M., Moral Torres, E., Río, J., Calles, C., Ares Luque, A., Ramió-Torrentà, L., Marzo Sola, M.E., Prieto, J.M., Martínez Ginés, M.L., Arroyo, R., Otano Martínez, M.Á., Brieva Ruiz, L., Gómez Gutiérrez, M., Rodríguez-Antigüedad Zarranz, A., Sánchez-Seco, V.G., Costa-Frossard, L., Hernández Pérez, M.Á., Landete Pascual, L., González Platas, M., Oreja-Guevara, C.

Publikováno v: In Neurología March 2024 39(2):196-208

Increased EBNA1-specific antibody response in primary-progressive multiple sclerosis.

Autor: Comabella M; Servei de Neurologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.; Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED)-ISCIII, Madrid, Spain., Hegen H; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria., Villar LM; Departments of Neurology and Immunology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigacion Sanitaria, Madrid, Spain., Rejdak K; Department of Neurology, Medical University of Lublin, Lublin, Poland., Sao-Avilés A; Servei de Neurologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Behrens M; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany., Sastre-Garriga J; Servei de Neurologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Mongay N; Servei de Neurologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Berek K; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria., Martínez-Yelamos S; Department of Neurology, Bellvitge University Hospital, Barcelona, Spain., Pérez-Miralles F; Neuroimmunology Unit, València University and Polytechnic Hospital La Fe, València, Spain., Abdelhak A; Department of Neurology, Ulm University, Ulm, Germany.; Division of Neuroinflammation and Glial Biology, Department of Neurology, University of California San Francisco, San Francisco, USA., Bachhuber F; Department of Neurology, Ulm University, Ulm, Germany., Tumani H; Department of Neurology, Ulm University, Ulm, Germany., Lycke J; Fundación INCE (Iniciativa Para Las Neurociencias), Madrid, Spain., Carbonell-Mirabent P; Servei de Neurologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Valls-Carbó A; Fundación INCE (Iniciativa Para Las Neurociencias), Madrid, Spain., Rosenstein I; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Alvarez-Lafuente R; Environmental Factors in Degenerative Diseases Research Group, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain., Castillo-Triviño T; Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED)-ISCIII, Madrid, Spain.; Neurology Department, Hospital Universitario Donostia, San Sebastián, Spain., Otaegui D; Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED)-ISCIII, Madrid, Spain.; Multiple Sclerosis Unit, Biodonostia Health Research Institute, San Sebastián, Spain., Llufriu S; Neuroimmunology and Multiple Sclerosis Unit, Service of Neurology, Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain., Blanco Y; Neuroimmunology and Multiple Sclerosis Unit, Service of Neurology, Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain., Sánchez-López AJ; Neuroimmunology Unit, Puerta de Hierro-Segovia de Arana Health Research Institute, Madrid, Spain.; Biobank, Puerta de Hierro-Segovia de Arana Health Research Institute, Madrid, Spain., García-Merino A; Neuroimmunology Unit, Puerta de Hierro-Segovia de Arana Health Research Institute, Madrid, Spain., Fissolo N; Servei de Neurologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.; Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED)-ISCIII, Madrid, Spain., Gutiérrez L; Servei de Neurologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Villacieros-Álvarez J; Servei de Neurologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Monreal E; Department of Neurology, Hospital Universitario Ramón y Cajal, REEM, IRYCIS, Universidad de Alcalá, Madrid, Spain., Wiendl H; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany., Montalban X; Servei de Neurologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Lünemann JD; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany. Jan.Luenemann@ukmuenster.de.

Publikováno v: Journal of neurology [J Neurol] 2024 Dec 12; Vol. 272 (1), pp. 26. Date of Electronic Publication: 2024 Dec 12.

Guía de tratamiento del deterioro de la marcha con fampridina de liberación prolongada (Fampyra®) en pacientes con esclerosis múltiple

Autor: Ramió-Torrentà, L., Álvarez-Cermeño, J.C., Arroyo, R., Casanova-Estruch, B., Fernández, O., García-Merino, J.A., Hernández, M.A., Izquierdo, G., Martínez-Yélamos, S., Meca, J., Moral, E., Olascoaga, J., Prieto, J.M., Saiz, A.

Publikováno v: In Neurología June 2018 33(5):327-337

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

21015. LACOSAMIDA VERSUS GABAPENTINA TRAS EL FRACASO A CARBAMAZEPINA EN EL TRATAMIENTO DE LA NEURALGIA DEL TRIGÉMINO: ESTUDIO RETROSPECTIVO

Autor: Valín Villanueva, P., Angerri, M., Tena Cucuala, R., Campoy, S., Martínez Yélamos, S., Huerta Villanueva, M., Muñoz, A.

Publikováno v: In Neurology Perspectives November 2024 4 Supplement 1:164-165